Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02018536 · ClinicalTrials.gov registry record · Phase 1
A Study to Investigate the Safety, Tolerability and Pharmacokinetics of GSK2336805 Alone and With the Co-administration of TMC435 in Healthy Japanese Participants.
A Phase 1 study, sponsored by Janssen R&D Ireland.
- Completed
- Registry status
- Phase 1
- Development phase
- 48
- Enrollment target
NCT02018536: Completed Phase 1 study, sponsored by Janssen R&D Ireland.
NCT02018536 is a Phase 1 study that has completed, run by Janssen R&D Ireland. The registered enrollment target is 48 participants, below the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (20% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02018536, a Phase 1 study, has completed, sponsored by Janssen R&D Ireland.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 48 participants
- Enrollment target
Study Summary
The purpose of the study is to investigate the safety, tolerability, and pharmacokinetic (what the body does to a medication) of GSK2336805 alone and with the co-administration of TMC435 in healthy Japanese participants.
Interventions
- DRUG GSK2336805 60 mg
- DRUG GSK2336805 30 mg
- DRUG GSK2336805 120 mg
- DRUG TMC435 150 mg (Treatment A)
- DRUG GSK2336805 60 mg (Treatment B and part of Treatment C and D)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 48 participants |
| Start Date | 2013-10 |
| Est. Completion | 2014-03 |
| Phase | Phase 1 |
What the finished NCT02018536 record still lists
NCT02018536 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 48 participants, a relatively small participant target, below the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (20% lower).
The record links to 0 conditions, and to 5 interventions - of which GSK2336805 60 mg is the first listed.
NCT02018536 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02018536 about?
NCT02018536 is a clinical study titled "A Study to Investigate the Safety, Tolerability and Pharmacokinetics of GSK2336805 Alone and With the Co-administration of TMC435 in Healthy Japanese Participants.". The purpose of the study is to investigate the safety, tolerability, and pharmacokinetic (what the body does to a medication) of GSK2336805 alone and with the co-administration of TMC435 in healthy Japanese participants.
What is the current status of trial NCT02018536?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 48 participants. The study started on 2013-10. Estimated completion is 2014-03.
What interventions are being tested in trial NCT02018536?
The interventions under investigation include: GSK2336805 60 mg (DRUG), GSK2336805 30 mg (DRUG), GSK2336805 120 mg (DRUG), TMC435 150 mg (Treatment A) (DRUG), GSK2336805 60 mg (Treatment B and part of Treatment C and D) (DRUG).
Who is sponsoring clinical trial NCT02018536?
This trial is sponsored by Janssen R&D Ireland, which has 14 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02018536's enrollment target sits among peer trials
48 1025th of 2000 higher than 948 of 2,000 other Phase 1 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01765777 · 48 participants · NA
Efficacy of Osteopathic Manipulative Medicine (OMM) and Phototherapy for Patients With Chronic Lower Back Pain
- NCT03073343 · 48 participants · NA
A Prospective, Randomized, Open Label Trial of Two Doses of Oral Betaine
- NCT03431064 · 48 participants
Lung Recruitment Maneuver as a Potential Predictor of Fluid Responsiveness in Mechanically Ventilated Pediatric Patients
- NCT03514602 · 48 participants · NA
Maternal Smoking Cessation and Pediatric Obesity Prevention
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia